Head & Neck · 2020 · 12 citations · 18 references
MedicineOncologySurgeryNeck OncologyOncologic SurgerySurgical OncologyRecurrent Neck CancerSquamous Cell CarcinomaNeoadjuvant ChemoradiotherapyOverall Survival After RecurrencePerineural Invasion AssessmentPerineural Invasion ManagementPerineural Invasion PrognosisSalvageSalvage TreatmentSecond Primary Tumors
BACKGROUND: The purpose of the study was to evaluate the oncological outcomes of salvage surgery in squamous cell carcinoma of the head and neck (SCCHN). METHODS: This is a retrospective analysis of all patients of SCCHN with recurrence or second primary, post-treatment, who underwent salvage surgery. The outcomes were analyzed in terms of overall survival, overall survival postsalvage surgery and disease-free survival (DFS) postsalvage surgery. Clinical and pathological predictors were considered. RESULTS: Two hundred and forty-one patients were included. The mean follow-up was 56.33 months. Five-year survival OS from date of initial diagnosis of the tumor was 61.2%. The 5-year OS survival after salvage surgery was 47.1%. Five-year DFS after salvage surgery was 28.1%. Prior chemoradiotherapy and pathological perineural invasion were independent predictors on multivariate analysis. CONCLUSIONS: Survival outcomes after appropriate salvage treatment are good. Prior chemoradiotherapy and perineural invasion on salvage pathology are predictors of poorer outcomes.
18
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2016 · 16.2K citations · Full text
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
Marshall R. Posner, Diáne Hershock, C. Blajman et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text
Medicine, Oncology, Chemotherapy +8
Bruce Brockstein, Daniel J. Haraf, Alfred Rademaker et al. · Annals of Oncology · 2004 · 374 citations · Full text